FDA Approved: BOSENTAN — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Bosentan from Actavis Pharma, authorizing a generic version under ANDA207110.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Bosentan (Bosentan)

Snippet

SUPPL AP for BOSENTAN (BOSENTAN)